|
1
|
Li PD, Wang XJ, Shan Q, Wu YH and Wang Z:
Evaluation of TAZ expression and its effect on tumor invasion and
metastasis in human glioma. Asian Pac J Trop Med. 7:757–760. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brat DJ, Scheithauer BW, Fuller GN and
Tihan T: Newly codified glial neoplasms of the 2007 WHO
classification of tumours of the central nervous system:
Angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain
Pathol. 17:319–324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hagemann C, Fuchs S, Monoranu CM, Herrmann
P, Smith J, Hohmann T, Grabiec U, Kessler AF, Dehghani F, Löhr M,
et al: Impact of MACC1 on human malignant glioma progression and
patients' unfavorable prognosis. Neuro Oncol. 15:1696–1709. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cuezva JM, Ortega AD, Willers I,
Sánchez-Cenizo L, Aldea M and Sánchez-Aragó M: The tumor suppressor
function of mitochondria: Translation into the clinics. Biochim
Biophys Acta. 1792:1145–1158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kroemer G and Pouyssegur J: Tumor cell
metabolism: Cancer's Achilles' heel. Cancer Cell. 13:472–482. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Faccenda D, Tan CH, Seraphim A, Duchen MR
and Campanella M: IF1 limits the apoptotic-signalling cascade by
preventing mitochondrial remodelling. Cell Death Differ.
20:686–697. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sánchez-Cenizo L, Formentini L, Aldea M,
Ortega AD, García-Huerta P, Sánchez-Aragó M and Cuezva JM:
Up-regulation of the ATPase inhibitory factor 1 (IF1) of the
mitochondrial H+-ATP synthase in human tumors mediates the
metabolic shift of cancer cells to a Warburg phenotype. J Biol
Chem. 285:25308–25313. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Formentini L, Sánchez-Aragó M,
Sánchez-Cenizo L and Cuezva JM: The mitochondrial ATPase inhibitory
factor 1 triggers a ROS-mediated retrograde prosurvival and
proliferative response. Mol Cell. 45:731–742. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sánchez-Aragó M, Formentini L,
Martinez-Reyes I, García-Bermudez J, Santacatterina F,
Sánchez-Cenizo L, Willers IM, Aldea M, Nájera L, Juarránz A, et al:
Expression, regulation and clinical relevance of the ATPase
inhibitory factor 1 in human cancers. Oncogenesis. 2:e462013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song R, Song H, Liang Y, Yin D, Zhang H,
Zheng T, Wang J, Lu Z, Song X, Pei T, et al: Reciprocal activation
between ATPase inhibitory factor 1 and NF-kappaB drives
hepatocellular carcinoma angiogenesis and metastasis. Hepatology.
60:1659–1673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
World Medical Association, . World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tu K, Li C, Zheng X, Yang W, Yao Y and Liu
Q: Prognostic significance of miR-218 in human hepatocellular
carcinoma and its role in cell growth. Oncol Rep. 32:1571–1577.
2014.PubMed/NCBI
|
|
14
|
Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C,
Yao Y and Liu Q: Fbxw7 is an independent prognostic marker and
induces apoptosis and growth arrest by regulating YAP abundance in
hepatocellular carcinoma. Mol Cancer. 13:1102014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li C, Yang W, Zhang J, Zheng X, Yao Y, Tu
K and Liu Q: SREBP-1 has a prognostic role and contributes to
invasion and metastasis in human hepatocellular carcinoma. Int J
Mol Sci. 15:7124–7138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Calzia D, Candiani S, Garbarino G, Caicci
F, Ravera S, Bruschi M, Manni L, Morelli A, Traverso CE, Candiano
G, et al: Are rod outer segment ATP-ase and ATP-synthase activity
expression of the same protein? Cell Mol Neurobiol. 33:637–649.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
ZarcoZavala M, Morales-Ríos E,
Mendoza-Hernández G, Ramírez-Silva L, Pérez-Hernández G and
García-Trejo JJ: The ζ subunit of the F1FO-ATP synthase of
α-proteobacteria controls rotation of the nanomotor with a
different structure. FASEB J. 28:2146–2157. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katoh M and Katoh M: Integrative genomic
analyses of ZEB2: Transcriptional regulation of ZEB2 based on
SMADs, ETS1, HIF1alpha, POU/OCT and NF-kappaB. Int J Oncol.
34:1737–1742. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bhat KP, Salazar KL, Balasubramaniyan V,
Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL,
Kim SH, et al: The transcriptional coactivator TAZ regulates
mesenchymal differentiation in malignant glioma. Genes Dev.
25:2594–2609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katsuno Y, Lamouille S and Derynck R:
TGF-β signaling and epithelial-mesenchymal transition in cancer
progression. Curr Opin Oncol. 25:76–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mahabir R, Tanino M, Elmansuri A, Wang L,
Kimura T, Itoh T, Ohba Y, Nishihara H, Shirato H, Tsuda M and
Tanaka S: Sustained elevation of Snail promotes glial-mesenchymal
transition after irradiation in malignant glioma. Neuro Oncol.
16:671–685. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan YR, Xie Q, Li F, Zhang Y, Ma JW, Xie
SM, Li HY and Zhong XY: Epithelial-to-mesenchymal transition is
involved in BCNU resistance in human glioma cells. Neuropathology.
34:128–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
